Showing results (341-350 of 406) with videos related to

Sort By:
Pageof 41
Microbiome|August 24, 2021
Blockage of bacterial FimH prevents mucosal inflammation associated with Crohn's diseaseGrégoire Chevalier, Arnaud Laveissière, Guillaume Desachy, et al.
BMC Gastroenterology|December 17, 2014
Early life environment and natural history of inflammatory bowel diseasesAbra Y Guo, Betsy W Stevens, Robin G Wilson, et al.
BMC Medical Genetics|October 13, 2006
Triglyceride associated polymorphisms of the APOA5 gene have very different allele frequencies in Pune, India compared to EuropeansGiriraj R Chandak, Kirsten J Ward, Chittaranjan S Yajnik, et al.
Lancet (London, England)|April 21, 2018
Origins of lifetime health around the time of conception: causes and consequencesTom P Fleming, Adam J Watkins, Miguel A Velazquez, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 15, 2019
Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel DiseasesJordan E Axelrad, Ahmad Bazarbashi, James Zhou, et al.
Inflammatory Bowel Diseases|November 29, 2016
Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's DiseaseKimberley W J Van Der Sloot, Amit D Joshi, Danielle R Bellavance, et al.
Immunity|April 22, 2014
Treg cells expressing the coinhibitory molecule TIGIT selectively inhibit proinflammatory Th1 and Th17 cell responsesNicole Joller, Ester Lozano, Patrick R Burkett, et al.
Journal of Epidemiology and Community Health|June 17, 2018
Growth and body composition of children aged 2-4 years after exposure to community mobilisation women's groups in BangladeshEdward Fottrell, Naveed Ahmed, Badrun Nahar, et al.
Nature|October 2, 2003
Hedgehog is an early and late mediator of pancreatic cancer tumorigenesisSarah P Thayer, Marina Pasca di Magliano, Patrick W Heiser, et al.
Crohn'S & Colitis 360|August 20, 2019
Immunologic Alterations Associated With Oral Delivery of Anti-CD3 (OKT3) Monoclonal Antibodies in Patients With Moderate-to-Severe Ulcerative ColitisElisa K Boden, James B Canavan, Christopher J Moran, et al.
Pageof 41